Deconstructing PML-induced premature senescence

EMBO Journal

Volumn 21, Issue 13, 2002, Pages 3358-3369

  Bischof, Oliver ^a   Kirsh, Olivier ^a   Pearson, Mark ^a   Itahana, Koji ^a   Pelicci, Pier Giuseppe ^a   Dejean, Anne ^a  

^a INSERM   (France)

Author keywords

p53; PML; PML nuclear bodies; Senescence; Telomerase

Indexed keywords

LYSINE; PROTEIN P53; RAS PROTEIN; SERINE; TELOMERASE;

ACETYLATION; ANIMAL CELL; ARTICLE; CELL METABOLISM; CONTROLLED STUDY; FIBROBLAST; MOLECULAR MECHANICS; MOLECULAR STABILITY; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SENESCENCE;

ACETYLATION; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, NUCLEAR; AUTOANTIGENS; CARRIER PROTEINS; CELL AGING; CELL NUCLEUS; DNA-BINDING PROTEINS; FIBROBLASTS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROMOLECULAR SUBSTANCES; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; NUCLEAR PROTEINS; ORGANELLES; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS P21(RAS); REACTIVE OXYGEN SPECIES; RECOMBINANT FUSION PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; SUMO-1 PROTEIN; TELOMERASE; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA;

EID: 0036646102     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/cdf341     Document Type: Article

References (58)

1. The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein
2. Post-translational modifications and activation of p53 by genotoxic stresses
3. Regulation and localization of the Bloom syndrome protein in response to DNA damage
4. Extension of life-span by introduction of telomerase into normal human cells
5. Tumor suppressors and oncogenes in cellular senescence
6. Cellular senescence as a tumor-suppressor mechanism
7. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis
8. The PML-RAR α fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR
9. A biomarker that identifies senescent human cells in culture and in aging skin in vivo
10. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
11. WAF1, a potential mediator of p53 tumor suppression
12. DNA viruses and viral proteins that interact with PML nuclear bodies
13. Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival
14. PML is induced by oncogenic ras and promotes premature senescence
15. Regulation of p53 activity in nuclear bodies by a specific PML isoform
16. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia
17. The serial cultivation of human diploid cell strains
18. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2
19. PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1
20. Regulation of cellular senescence by p53
21. PML protein isoforms and the RBCC/TRIM motif
22. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML
23. Identification of three major sentrinization sites in PML
24. Fusion proteins between PML and α-RAR in acute promyelocytic leukemia
25. The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion
26. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment and As203-induced PML or PML/retinoic acid receptor α degradation
27. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence
28. 1 cell cycle arrest and apoptosis
29. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species
30. Genes involved in senescence and immortalization
31. Negative control of p53 by Sir2α promotes cell survival under stress
32. Cell senescence and cancer
33. PML, a growth suppressor disrupted in acute promyelocytic leukemia
34. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption
35. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus
36. Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot
37. Evidence for separate ND10-binding and homo-oligomerization domains of Sp100
38. PML interaction with p53 and its role in apoptosis and replicative senescence
39. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
40. High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth
41. The p53 pathway
42. The PML nuclear bodies: Actors or extras?
43. SUMO: Of branched proteins and nuclear bodies
44. Putting the stress on senescence
45. Telomeres and telomerase: Implications for cancer and aging
46. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1
47. Telomerase and human tumorigenesis
48. Regulation of reactive-oxygen-species generation in fibroblasts by Racl
49. p53 mutant mice that display early ageing-associated phenotypes
50. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span
51. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase
52. Role of PML in cell growth and the retinoic acid pathway
53. Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts
54. Retinoic acid regulates aberrant nuclear localization of PML-RAR α in acute promyelocytic leukemia cells
55. 2 phases in immortalized telomerase-negative cells. Implication of NBS1 in alternative lengthening of telomeres
56. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body
57. Role of SUMO-1-modified PML in nuclear body formation
58. The transcriptional role of PML and the nuclear body